이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Calumet Specialty Products Partners 관리

관리 기준 확인 4/4

Calumet Specialty Products Partners' CEO는 Louis Borgmann, May2022 에 임명되었습니다 의 임기는 2.08 년입니다. 총 연간 보상은 $ 2.50M, 29.4% 로 구성됩니다. 29.4% 급여 및 70.6% 보너스(회사 주식 및 옵션 포함). 는 $ 2.64M 가치에 해당하는 회사 주식의 0.2% 직접 소유합니다. 2.64M. 경영진과 이사회의 평균 재임 기간은 각각 2.7 년과 5.7 년입니다.

주요 정보

Louis Borgmann

최고 경영자

US$2.5m

총 보상

CEO 급여 비율	29.4%
CEO 임기	2.2yrs
CEO 소유권	0.2%
경영진 평균 재임 기간	2.8yrs
이사회 평균 재임 기간	5.8yrs

최근 관리 업데이트

Recent updates

Many Still Looking Away From Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT)

Jun 10

Calumet Specialty Products Endured Rainy Days With Blue Skies Ahead

May 19

Investors Will Want Calumet Specialty Products Partners' (NASDAQ:CLMT) Growth In ROCE To Persist

Apr 01

Calumet Specialty Products: Huge Increases In Cash Flows May Be Imminent [Downgrade]

Mar 18

LVS Advisory - Calumet: Fits Firmly Within The 'Moderate Risk, High Reward' Portfolio Bucket

Feb 11

CEO 보상 분석

Louis Borgmann 의 보수는 Calumet Specialty Products Partners 의 수익과 비교하여 어떻게 변경되었나요?
날짜	총 보상	급여	회사 수익
Mar 31 2024	n/a	n/a	-US$12m
Dec 31 2023	US$3m	US$735k	US$47m
Sep 30 2023	n/a	n/a	US$24m
Jun 30 2023	n/a	n/a	-US$61m
Mar 31 2023	n/a	n/a	-US$58m
Dec 31 2022	US$4m	US$569k	-US$170m
Sep 30 2022	n/a	n/a	-US$179m
Jun 30 2022	n/a	n/a	-US$143m
Mar 31 2022	n/a	n/a	-US$205m
Dec 31 2021	US$1m	US$334k	-US$255m

보상 대 시장: Louis 의 총 보상 ($USD 2.50M ) US 시장에서 비슷한 규모의 회사에 대한 평균보다 낮습니다( $USD 5.67M ).

보상과 수익: Louis 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

Louis Borgmann (41 yo)

2.2yrs

테뉴어

US$2,502,040

보상

Mr. Louis Todd Borgmann has been Chief Executive Officer at Calumet GP, LLC, General Partner of Calumet Specialty Products Partners, L.P from May 1, 2022. He serves as Chief Executive Officer of Montana Re...

리더십 팀

이름	위치	테뉴어	보상	소유권
Louis Borgmann	Chief Executive Officer of Calumet GP	2.2yrs	US$2.50m	0.20% $ 2.6m
Vincent Donargo	Chief Accounting Officer & Principal Accounting Officer	less than a year	US$434.40k	0.011% $ 146.4k
Gregory Morical	Senior VP	12.3yrs	US$864.50k	0.042% $ 543.2k
Bruce Fleming	Executive Vice President of Montana Renewables & Corporate Development of Calumet GP	3.4yrs	US$2.23m	0.60% $ 7.7m
Scott Obermeier	Executive Vice President of Specialties of Calumet GP	4.5yrs	US$765.61k	0.26% $ 3.3m
David Lunin	Executive VP & CFO of Calumet GP	less than a year	데이터 없음	데이터 없음
John Kompa	Director of Investor Relations	no data	데이터 없음	데이터 없음
Chris Hodges	Alpha IR	no data	데이터 없음	데이터 없음

2.8yrs

평균 재임 기간

53yo

평균 연령

경험이 풍부한 관리: CLMT 의 관리팀은 경험 ( 2.7 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Karen Twitchell	Independent Director of Calumet GP	1.9yrs	US$201.00k	데이터 없음
John Boss	Independent Director of Calumet GP	1.9yrs	US$226.11k	0.031% $ 401.3k
Paul Raymond	Director of Calumet GP	3.7yrs	US$220.00k	0.0087% $ 111.7k
Stephen Mawer	Chairman of the Board of Calumet GP	8.3yrs	US$1.30m	0.21% $ 2.8m
James Carter	Independent Director of Calumet GP	18.5yrs	US$235.33k	0.40% $ 5.1m
Jennifer Straumins	Director of Calumet GP	3.4yrs	US$185.00k	0.83% $ 10.6m
Daniel Sheets	Independent Director of Calumet GP	5.8yrs	US$238.00k	0.076% $ 986.6k
Amy Schumacher	Director of Calumet GP	9.8yrs	US$212.00k	0.24% $ 3.1m
Daniel Sajkowski	Director of Calumet GP	9.8yrs	US$188.75k	0.19% $ 2.5m

5.8yrs

평균 재임 기간

64yo

평균 연령

경험이 풍부한 이사회: CLMT 의 이사회는 경험(평균 재직 기간 5.7 년)으로 간주됩니다.

Calumet Specialty Products Partners 관리

관리 기준 확인 4/4

주요 정보

최근 관리 업데이트

Senior VP recently sold US$167k worth of stock

Chairman of the Board of Calumet GP exercised options and sold US$269k worth of stock

Calumet Specialty Products Partners, L.P. to Appoint David Lunin as EVP on January 1, 2024

Calumet Specialty Products Partners, L.P. Announces CFO Changes

Insider recently bought US$82k worth of stock

Key Executive recently bought US$57k worth of stock

Recent updates

Consensus EPS estimates fall by 19%

Price target decreased by 7.5% to US$20.90

Many Still Looking Away From Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT)

Consensus EPS estimates fall by 95%

Calumet Specialty Products Endured Rainy Days With Blue Skies Ahead

Senior VP recently sold US$167k worth of stock

First quarter 2024 earnings released: US$0.51 loss per share (vs US$0.35 profit in 1Q 2023)

Calumet Specialty Products Partners, L.P. to Report Q1, 2024 Results on May 10, 2024

Consensus EPS estimates increase from loss to US$0.226 profit

Investors Will Want Calumet Specialty Products Partners' (NASDAQ:CLMT) Growth In ROCE To Persist

Consensus EPS estimates upgraded to US$0.18 loss

Calumet Specialty Products: Huge Increases In Cash Flows May Be Imminent [Downgrade]

New major risk - Earnings quality

New minor risk - Earnings quality

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Calumet Specialty Products Partners, L.P. to Report Q4, 2023 Results on Feb 23, 2024

LVS Advisory - Calumet: Fits Firmly Within The 'Moderate Risk, High Reward' Portfolio Bucket

Calumet Specialty Products: Falling Knifes And Investor Irrationality

Chairman of the Board of Calumet GP exercised options and sold US$269k worth of stock

Consensus EPS estimates increase by 12%

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Calumet Specialty Products Partners, L.P. to Report Q3, 2023 Results on Nov 09, 2023

Calumet Specialty Products Partners, L.P. to Appoint David Lunin as EVP on January 1, 2024

Calumet Specialty Products Partners, L.P. Announces CFO Changes

Second quarter 2023 earnings: EPS misses analyst expectations

Calumet Specialty Products Partners, L.P. to Report Q2, 2023 Results on Aug 04, 2023

Insider recently bought US$82k worth of stock

First quarter 2023 earnings released: EPS: US$0.35 (vs US$1.18 loss in 1Q 2022)

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Now 25% undervalued

Price target decreased to US$25.28

Key Executive recently bought US$57k worth of stock

Less than half of directors are independent

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Calumet Specialty Products Partners, L.P. Appoints Steve Mawer as Chairman of the Board, Effective from January 1, 2023

Calumet Specialty Products Partners, L.P. to Report Q3, 2022 Results on Nov 09, 2022

Calumet Specialty Products Blasted Off, The Cash Flow Went Solar

Price target increased to US$26.20

Insider recently bought US$101k worth of stock

Second quarter 2022 earnings released: US$0.19 loss per share (vs US$0.97 loss in 2Q 2021)

Calumet Specialty Q2 2022 Earnings Preview

Calumet Specialty Products Partners, L.P. Announces Additions to Board of Directors

The Final Countdown For Calumet Specialty Products' Launch Continues

Calumet Specialty Products Partners, L.P. to Report Q2, 2022 Results on Aug 05, 2022

Consensus estimates of losses per share improve by 11%

Consensus estimates of losses per share improve by 14%

It's The Final Countdown For Calumet Specialty Products

Consensus forecasts updated

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Consensus forecasts updated

Less than half of directors are independent

Consensus forecasts updated

Calumet Specialty Products Partners, L.P. to Report Q1, 2022 Results on May 06, 2022

Consensus forecasts updated

Calumet Specialty Products Partners, L.P. Always Landing On Its Feet

Full year 2021 earnings: EPS and revenues miss analyst expectations

Calumet Specialty Products Partners, L.P. Announces That Fred Fehsenfeld, Chairman of the Board of the General Partner Elected to Retire Effective May 1, 2022

Calumet Specialty Products Partners, L.P. to Report Q4, 2021 Results on Feb 25, 2022

Evaluating Calumet's Apparent Conservative Equity Valuation

Forecast breakeven date pushed back to 2023

Calumet Specialty Products Calls All Aboard

Price target decreased to US$19.10

Third quarter 2021 earnings released: EPS US$0.64 (vs US$0.70 loss in 3Q 2020)

Frantic Buying At Calumet Specialty Products

Price target increased to US$9.20

For Calumet, Progress Marches

Second quarter 2021 earnings released: US$0.97 loss per share (vs US$0.044 profit in 2Q 2020)

Consensus forecasts updated

Price target increased to US$7.00